299 related articles for article (PubMed ID: 30971629)
1. Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy.
Ge ZD; Lian Q; Mao X; Xia Z
Int Heart J; 2019 May; 60(3):512-520. PubMed ID: 30971629
[TBL] [Abstract][Full Text] [Related]
2. Overview of Nrf2 as Therapeutic Target in Epilepsy.
Carmona-Aparicio L; Pérez-Cruz C; Zavala-Tecuapetla C; Granados-Rojas L; Rivera-Espinosa L; Montesinos-Correa H; Hernández-Damián J; Pedraza-Chaverri J; Sampieri A; Coballase-Urrutia E; Cárdenas-Rodríguez N
Int J Mol Sci; 2015 Aug; 16(8):18348-67. PubMed ID: 26262608
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease.
Zhang C; Shi Y; Liu C; Sudesh SM; Hu Z; Li P; Liu Q; Ma Y; Shi A; Cai H
Cardiovasc Diabetol; 2024 May; 23(1):169. PubMed ID: 38750502
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
Tan Y; Zhang Z; Zheng C; Wintergerst KA; Keller BB; Cai L
Nat Rev Cardiol; 2020 Sep; 17(9):585-607. PubMed ID: 32080423
[TBL] [Abstract][Full Text] [Related]
5. Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex-specific differences of glucose-lowering therapies on the diabetic heart: IUPHAR Review 33.
Sharma A; De Blasio M; Ritchie R
Br J Pharmacol; 2023 Nov; 180(22):2916-2933. PubMed ID: 35174479
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic Insights and Potential Therapeutic Implications of NRF2 in Diabetic Encephalopathy.
Cheng X; Tan Y; Li H; Zhang Z; Hui S; Zhang Z; Peng W
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38483656
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets.
Ye W; Han K; Xie M; Li S; Chen G; Wang Y; Li T
Chin Med J (Engl); 2024 Apr; 137(8):936-948. PubMed ID: 38527931
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline.
Nguyen V; Taine EG; Meng D; Cui T; Tan W
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542359
[TBL] [Abstract][Full Text] [Related]
9. Bile acid receptor protects against diabetic cardiomyopathy.
Fernández-Ruiz I
Nat Rev Cardiol; 2024 May; ():. PubMed ID: 38769466
[No Abstract] [Full Text] [Related]
10. Bile acids for diabetic cardiomyopathy.
Weissman D; Maack C
Nat Metab; 2024 May; ():. PubMed ID: 38698280
[No Abstract] [Full Text] [Related]
11. Nrf2 as a potential target for the treatment of epilepsy.
Singh PK; Shekh-Ahmad T
Neural Regen Res; 2024 Sep; 19(9):1865-1866. PubMed ID: 38227501
[No Abstract] [Full Text] [Related]
12. Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice.
Zang H; Wu W; Qi L; Tan W; Nagarkatti P; Nagarkatti M; Wang X; Cui T
Diabetes; 2020 Dec; 69(12):2720-2734. PubMed ID: 32948607
[TBL] [Abstract][Full Text] [Related]
13. Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy.
Chen Y; Hua Y; Li X; Arslan IM; Zhang W; Meng G
Front Pharmacol; 2020; 11():42. PubMed ID: 32116717
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress.
Li W; Li W; Leng Y; Xiong Y; Xia Z
DNA Cell Biol; 2020 Feb; 39(2):210-225. PubMed ID: 31809190
[TBL] [Abstract][Full Text] [Related]
15. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury.
Li N; Wang W; Zhou H; Wu Q; Duan M; Liu C; Wu H; Deng W; Shen D; Tang Q
Free Radic Biol Med; 2020 Nov; 160():303-318. PubMed ID: 32846217
[TBL] [Abstract][Full Text] [Related]
16. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis.
Fang X; Cai Z; Wang H; Han D; Cheng Q; Zhang P; Gao F; Yu Y; Song Z; Wu Q; An P; Huang S; Pan J; Chen HZ; Chen J; Linkermann A; Min J; Wang F
Circ Res; 2020 Jul; 127(4):486-501. PubMed ID: 32349646
[TBL] [Abstract][Full Text] [Related]
17. The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.
Ravingerová T; Kindernay L; Barteková M; Ferko M; Adameová A; Zohdi V; Bernátová I; Ferenczyová K; Lazou A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114290
[TBL] [Abstract][Full Text] [Related]
18. Diabetic Cardiomyopathy.
Dillmann WH
Circ Res; 2019 Apr; 124(8):1160-1162. PubMed ID: 30973809
[TBL] [Abstract][Full Text] [Related]
19. Targeting the pathways of regulated necrosis: a potential strategy for alleviation of cardio-cerebrovascular injury.
Lu LQ; Tian J; Luo XJ; Peng J
Cell Mol Life Sci; 2021 Jan; 78(1):63-78. PubMed ID: 32596778
[TBL] [Abstract][Full Text] [Related]
20. Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.
Del Re DP; Amgalan D; Linkermann A; Liu Q; Kitsis RN
Physiol Rev; 2019 Oct; 99(4):1765-1817. PubMed ID: 31364924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
